Corrigendum: Fucosylated antigens in cancer: An alliance toward tumor progression, metastasis, and resistance to chemotherapy [Front Oncol, 8, (2018) (39)] DOI: 10.3389/fonc.2018.00039

5Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

Abstract

We recently published our review with the title: "Fucosylated Antigens in Cancer: An Alliance Toward Tumor Progression, Metastasis, and Resistance to Chemotherapy" in Frontiers in Oncology. However, we noticed that there is a mistake in the abstract of the article. Specifically, the abstract mentions "endothelial to mesenchymal transition" instead of "epithelial to mesenchymal transition." We are submitting this Corrigendum in order to clarify the error and apologize for any confusion by the readers. The correct sentence should read: "Here, we review the relevance of tumor-overexpressed FUTs and their respective synthesized Lewis determinants in critical aspects associated with cancer progression, such as increased cell survival and proliferation, tissue invasion and metastasis, epithelial to mesenchymal transition, endothelial and immune cell interaction, angiogenesis, multidrug resistance, and cancer stemness".

Cite

CITATION STYLE

APA

Blanas, A., Sahasrabudhe, N. M., Rodríguez, E., van Kooyk, Y., & van Vliet, S. J. (2018, May 11). Corrigendum: Fucosylated antigens in cancer: An alliance toward tumor progression, metastasis, and resistance to chemotherapy [Front Oncol, 8, (2018) (39)] DOI: 10.3389/fonc.2018.00039. Frontiers in Oncology. Frontiers Media S.A. https://doi.org/10.3389/fonc.2018.00150

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free